Pharmacovigilance in Saudi Arabia

Pharmacovigilance in Saudi Arabia plays a crucial role in ensuring the safety and effectiveness of medicines used within the country. Overseen by the Saudi Food and Drug Authority (SFDA), the national pharmacovigilance system monitors adverse drug reactions (ADRs), medication errors, and product quality issues. Through the Saudi Vigilance Program, healthcare professionals, patients, and pharmaceutical companies are encouraged to report any suspected drug-related problems. The SFDA has implemented robust regulations aligned with international standards, aiming to enhance drug safety and protect public health. It also collaborates with global pharmacovigilance centers to share data and improve signal detection. Continuous education and awareness campaigns are helping to strengthen the culture of reporting and safety monitoring across the healthcare system. As the pharmaceutical market in Saudi Arabia grows, a strong pharmacovigilance framework remains essential for early risk identification, regulatory decision-making, and ensuring that the benefits of medications outweigh their risks.